Site Search
Search Results
2023 Oklahoma Legislative Priorities
... Legislative Priorities Victory in the fight against cancer requires bold new public policies that promote cancer prevention, early detection of cancer, and expand access to quality, affordable health care. Lawmakers make many decisions that impact the lives of Oklahomans impacted by cancer and their leadership is vital to defeating this disease. In 2023 the American Cancer Society Cancer Action Network (ACS CAN) will work with the Oklahoma Legislature on legislative and regulatory efforts that provide affordable, adequate access to health insurance ... will also support policies that encourage more copay-only plans, place limits on out-of-pocket costs for prescription drugs, and ensure that all cost-sharing payments are counted. Paid Family and Medical Leave: ACS CAN will advocate for legislation that ensures all working cancer patients, ...
New York Reduces Financial Barriers to Lifesaving Cancer Care
ALBANY, NY –12.23.22-- Earlier today, Governor Hochul signed two bills into law, both of which address gaps in New Yorkers’ access to affordable, lifesaving care for those facing a cancer diagnosis—or other chronic illness. The ... The details are as follows: A2085-A / S906-B, now Chapter 739, requires that every state-regulated large-group health plan cover 100% of the cost of colorectal cancer screening beginning at age 45 and removes cost-sharing for individuals who require a follow-up colonoscopy after a ... Hochul’s signature, state leaders have taken significant steps in ensuring that every New Yorker has access to affordable, lifesaving care. We can expect to reduce colorectal cancer incidence and mortality rates as well as the financial burden of a cancer diagnosis,” said Michael Davoli, ...
Obama Administration Clarifies Tobacco Cessation Benefit under the ACA
... tobacco cessation benefit under the Affordable Care Act. The ACA requires most health plans to cover tobacco cessation services at no cost to the enrolle, but implementation of this benefit has been inconsistent. Smokers have reported difficulties accessing treatments and having to pay for services that should have been free. ACS CAN along with its public health partners submitted a letter to HHS earlier this year asking for clarification to address these concerns. The ...
2025 Oklahoma Legislative Priorities
... Priorities Victory in the fight against cancer requires bold public policy solutions that promote cancer prevention, increase early detection of cancer, expand access to quality, affordable health care, reduce disparities and advance health equity. State and local lawmakers’ decisions impact the lives of those affected by cancer. In 2025, the American Cancer Society Cancer Action Network (ACS CAN) will work with members of the Oklahoma Legislature to prioritize state and local legislative and regulatory efforts that provide ... Genetic Testing Access: ACS CAN will advocate for policies that ensure access to clinically necessary genetic testing for cancer risk, without cost sharing. Prescription Drug Transparency: ACS CAN will continue to support legislation that allows cancer patients and all health consumers ...
House Energy & Commerce Committee Focuses on Strengthening Nation’s Health Care Law
Washington, D.C.— The House Energy and Commerce Committee will hold a hearing today—the eleventh anniversary of the signing of the Affordable Care Act (ACA) into law—on several bills aimed at strengthening the ACA. The bills include funding for outreach and enrollment ... is taking this opportunity to further strengthen the law. We look forward to continuing to work with all lawmakers on numerous ways they can help ensure cancer patients and their families have access to quality affordable health care now and in the years to come.” ### 0 House ...
2025-2026 Massachusetts Priorities
... samples (e.g., blood, tumor tissue) taken from a patient to identify and evaluate specific biomarkers. Research shows that targeted therapy can improve patient survival and quality of life. When doctors connect patients to the most effective treatment for their cancer, patients can avoid treatments that will be ineffective or ... consumers run the risk of picking the wrong plan, one that may not cover all their medications at a price they can afford. While the cost of a drug can vary significantly depending on the source, consumers who are increasingly facing co-insurance (rather than a fixed co-pay) must ...
Report Details Common Patient Barriers to Cancer Clinical Trial Enrollment
Washington, D.C.—The American Cancer Society Cancer Action Network (ACS CAN) today released a report examining the most common patient barriers to cancer clinical trial enrollment. Made public at ACS CAN’s annual ... in four (27%) patients has access to clinical trials where they are being treated. Yet, if asked to enroll in an available trial, more than half of eligible patients typically agree to do so. Of the patients who actively decline participation, the main factors cited include, fear of side effects, loss of control in their treatment, logistical issues for participation and cost concerns. “Clinical trials are an essential step toward advancing promising new cancer treatments and while most patients are willing to ...
Black Men and Prostate Cancer
... cancer. Prostate cancer rates for Black men are 70% higher than the rates for White men. What does the PSA Screening for HIM Act do? Screening can help find prostate cancer at an early stage often before any signs or symptoms are present and before the disease becomes more advanced and more difficult treat. However, out of pocket costs can be a barrier to accessing screening. The five-year survival rate for men diagnosed in early, local or regional stages is around ... for HIM) Act would require health insurance providers to cover prostate-specific antigen (PSA) blood tests for the highest risk patients at no cost. Throughout this document men refers to individuals assigned male at birth and/or persons with a prostate. Wolf, A. M., Wender, R. C., ...
Dr. Patrice High
Black Volunteer Caucus (BVC) > Meet the Caucus Members I am Dr. Patrice High from Columbia, SC. I am a wife, mother of a teenage son, a dual board-certified Family and Lifestyle Medicine physician teaching the power of lifestyle to prevent, improve and reverse disease in a telehealth practice format. My hobbies include purposeful movement by walking outdoors, group Zumba Classes and traveling (to name a few). My role in ACS CAN is as a legislative ambassador. I also had the pleasure of sharing as a panelist during the ACS-CAN Priorities and Partners meeting in ...
Dr. Patrice High
I am Dr. Patrice High from Columbia, SC. I am a wife, mother of a teenage son, a dual board-certified Family and Lifestyle Medicine physician teaching the power of lifestyle to prevent, improve and reverse disease in a telehealth practice format. My hobbies include purposeful movement by walking outdoors, group Zumba Classes and traveling (to name a few). My role in ACS CAN is as a legislative ambassador. I also had the pleasure of sharing as a panelist during the ACS-CAN Priorities and Partners meeting in ...
Type
- Action (3) Apply Action filter
- Basic page (109) Apply Basic page filter
- Blog Post (85) Apply Blog Post filter
- Event (29) Apply Event filter
- Landing Page (1) Apply Landing Page filter
- Press Release (1143) Apply Press Release filter
- Resource (69) Apply Resource filter
- State Priority (106) Apply State Priority filter
- Update (662) Apply Update filter
Priority Issue
State
- National (233) Apply National filter
- Maine (123) Apply Maine filter
- Massachusetts (120) Apply Massachusetts filter
- New York (117) Apply New York filter
- Vermont (117) Apply Vermont filter
- New Jersey (59) Apply New Jersey filter
- Connecticut (51) Apply Connecticut filter
- California (47) Apply California filter
- Ohio (45) Apply Ohio filter
- Pennsylvania (43) Apply Pennsylvania filter
- Maryland (34) Apply Maryland filter
- North Carolina (33) Apply North Carolina filter
- Michigan (32) Apply Michigan filter
- Florida (29) Apply Florida filter
- Tennessee (26) Apply Tennessee filter
- Kentucky (25) Apply Kentucky filter
- New Mexico (25) Apply New Mexico filter
- West Virginia (25) Apply West Virginia filter
- South Carolina (24) Apply South Carolina filter
- Wyoming (24) Apply Wyoming filter
- Illinois (22) Apply Illinois filter
- Texas (22) Apply Texas filter
- Oklahoma (21) Apply Oklahoma filter
- Colorado (20) Apply Colorado filter
- Georgia (20) Apply Georgia filter
- Missouri (20) Apply Missouri filter
- South Dakota (20) Apply South Dakota filter
- Arizona (19) Apply Arizona filter
- Indiana (18) Apply Indiana filter
- Nevada (18) Apply Nevada filter
- Oregon (18) Apply Oregon filter
- Arkansas (17) Apply Arkansas filter
- Montana (16) Apply Montana filter
- New Hampshire (16) Apply New Hampshire filter
- Rhode Island (16) Apply Rhode Island filter
- North Dakota (15) Apply North Dakota filter
- Alabama (14) Apply Alabama filter
- Idaho (13) Apply Idaho filter
- Utah (13) Apply Utah filter
- Virginia (13) Apply Virginia filter
- Louisiana (12) Apply Louisiana filter
- Minnesota (12) Apply Minnesota filter
- Mississippi (11) Apply Mississippi filter
- Kansas (10) Apply Kansas filter
- Nebraska (10) Apply Nebraska filter
- Washington (10) Apply Washington filter
- Alaska (9) Apply Alaska filter
- District Of Columbia (9) Apply District Of Columbia filter
- Hawaii (9) Apply Hawaii filter
- Delaware (8) Apply Delaware filter
Policy Issue
- Access to Health Care (19) Apply Access to Health Care filter
- Prevention and Early Detection (8) Apply Prevention and Early Detection filter
- Research, Funding and Drug Development (8) Apply Research, Funding and Drug Development filter
- Health Equity (4) Apply Health Equity filter
- Patient Quality of Life (3) Apply Patient Quality of Life filter